Speaker(s): 

Moderator(s): 

Michaelyn Notz, DO, Geisinger Staff Member - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• define Obstructive Sleep Apnea (OSA): Discuss the pathophysiology, diagnostic criteria, and prevalence of OSA, particularly in patients with comorbid conditions such as obesity and cardiovascular disease.
• evaluate the Health Consequences of Untreated OSA: Highlight the risks associated with untreated OSA, including cardiovascular morbidity, cognitive decline, and decreased quality of life.
• assess Barriers to Effective OSA Treatment: Examine the treatment gap, exploring barriers such as underdiagnosis, patient adherence issues, and access to continuous positive airway pressure (CPAP) therapy.
• discuss Potential Solutions to Reduce the Treatment Gap: Explore strategies to improve diagnosis rates, treatment adherence, and the accessibility of interventions, with a focus on the role of primary care and multidisciplinary approaches.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Michaelyn Notz, DO; Jeff Summers, DO and Jesse Calenstine, DO have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commerical Support for this Session

None